Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
PubMed laboratory research record [PMID: 33354706] PubMed record related to this compound for laboratory literature review
n general, doza uzual pentru aduli variaz ntre 500 mg i 2000 mg pe zi
Red flag symptoms that necessitate same-day medical contact include: Blood in stools (visible red blood or black, tarry stools) Severe abdominal pain that is persistent, severe, or radiating to the back (which may indicate pancreatitis, a rare but serious side effect) Signs of dehydration : decreased urination, dark urine, dizziness upon standing, extreme thirst, or confusion Fever above 100.4F (38C) accompanying diarrhea Pain in the upper right abdomen , possibly with fever or yellowing of skin/eyes (signs of gallbladder disease, which can occur with GLP-1 medications) Inability to keep down fluids due to concurrent vomiting If you experience severe vomiting or diarrhea leading to dehydration, you may need to temporarily pause your medication until speaking with your healthcare provider, as severe dehydration can lead to acute kidney injury
Semaglutide therapy may be used to address medically supervised weight reduction, obesity-related risk factors, and longer-term weight maintenance in appropriate candidates
Patients who begin at lower doses and advance gradually experience fewer severe symptoms than those who jump to higher doses quickly
